Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for Diffuse Diabetic Macular Edema
NCT00567372Phase 4Withdrawn
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Jun 2008
- Primary completion
- Nov 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab, sponsored by Asociación para Evitar la Ceguera en México. Planned start Jun 2008; status: withdrawn.
02
Drugs
bevacizumab
Beyond the preview
Go deeper on NCT00567372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567372.